Amcor (AMCR) delivered a quarter in which the underlying business improved while the earnings outlook got worse. Adjusted EPS of $0.95 fell a penny short of the $0.96 consensus and missed the $0.99 Earnings Whisper number by 4.0%. Earnings growth was 0.0% year over year. The company's own reconciliation shows adjusted EPS of $0.95 against a restated $0.97, down 2% reported and 3% in constant currency, so even the most generous reading is flat. Revenue of $6.129 billion beat the $5.83 billion consensus by 5.1% and grew 6.7%. The more consequential news was the cut to transition-period adjusted EPS guidance, from $1.80-$1.90 to $1.70-$1.80. Management attributed the cut to energy and distribution costs that accelerated late in the quarter. That is the central tension: volumes are recovering, but cost pass-through timing and cash conversion are moving the wrong way.
The revenue beat deserves scrutiny because it was almost entirely mechanical. Pass-through of higher raw-material costs added roughly $435 million, or 8 points of growth. Divestitures subtracted about 2 points. That left only about 1 point from volume and price/mix. Adjusted EBITDA of $883 million slipped 3% from $909 million, and adjusted EBIT of $689 million was essentially unchanged. The headline adjusted EBIT margin fell to 11.2% from 12.0%. Excluding the dilution from pass-through dollars, it was 12.1%, up just 10 basis points.
The segment detail was mixed. Flexibles improved comparable margin by 20 basis points. Rigid Packaging's comparable margin fell 20 basis points, and its adjusted EBIT declined 3%. GAAP EPS fell to $0.52 from $0.57, and SG&A rose 8%.
The call did preserve a credible growth story on volume. Organic volume rose 1%, the fourth consecutive quarter of sequential improvement:
- -1.5% in fiscal Q3 2026
- modestly positive in fiscal Q4 2026
- +1% this quarter
Focus categories grew 3%, led by pet food, foodservice, and beauty and wellness. Volumes rose in every region, and management said October volumes tracked September. The China business, roughly $1 billion, is growing at a high-single-digit pace with capacity additions underway.
Berry integration remains on plan. Quarterly cost synergies of about $60 million were in line with expectations, and the $650 million three-year target was reaffirmed. Growth synergy awards climbed to $170 million annualized, up from about $140 million last quarter and about $110 million the quarter before. Management now expects to exceed the $280 million target. A new private-label organization for North American and European retailers and co-packers adds another lever.
Bears have legitimate ammunition on costs and the balance sheet. Gross energy and distribution inflation exceeds $100 million, and only about half has been offset so far. Management insists the pressure will not affect 2027 results, a claim investors will have to take on faith for now. The cash picture is worse than the income statement:
- Free cash flow was an outflow of $820 million, versus $343 million a year ago.
- Net debt rose to $14.0 billion from $12.9 billion in June.
- A roughly $500 million working-capital build tied to Middle East resin volatility has seen no recovery. Last quarter, management expected $100-$300 million back within six months. That recovery is now pushed into 2027.
- Year-end leverage guidance moved to about 3.6x, the top of the prior range and well above the 3.1-3.2x originally planned for fiscal 2026.
The North American beverage divestiture is also taking longer than expected, and non-core volumes fell by low-to-mid single digits. The 2027 framework of double-digit EPS growth, mid-single-digit EBITDA growth and about 3.0x leverage remains intact, but it now requires a steeper recovery. The reduced six-month guidance implies roughly $0.75-$0.85 of adjusted EPS in the December quarter.
The market setup is more complicated than the modest miss implies. Earnings Whispers investor sentiment rose meaningfully into the report, from 0.27 to 0.50. Shares rallied about 15% off their October 8 low of $40.79 to an inter-earnings high of $49.04 on November 2, just two days before the release. At $46.96 heading into earnings, the stock sat 9.1% above its 200-day moving average and only 4.2% below that high. It was still down 2.2% from the open after the August report. Price, momentum and AVWAP trend readings were positive. In short, buyers had leaned into the volume-recovery narrative just before management lowered the near-term earnings bar and delayed the cash recovery.
The bottom line is that Amcor's operating trajectory is better than its headline numbers. Volumes, synergies and growth awards are all moving in the right direction. However, a whisper miss, flat earnings, a guidance cut and a deeper cash hole collided with elevated sentiment and a stock trading near the top of its range. The bull case now depends on management delivering the 2027 rebound it has promised, with less near-term financial cushion than investors expected three months ago.